Charts are never wrong, analysis is! Charts are never wrong, analysis is! DSIJ Intelligence-3 / Monday, January 25, 2021 / Article rating: 4.4 Scaling is an issue that is often overlooked in technical community, but since it can have an important influence on how trendlines can be interpreted, it should not be ignored at any cost. The difference between a logarithmic price chart and a linear price chart can be very slight when one is analysing a chart in the short-term, where price fluctuations are relatively small.
Strides Pharma slumps despite getting nod from USFDA for Ursodiol capsules Strides Pharma slumps despite getting nod from USFDA for Ursodiol capsules DSIJ Intelligence / Monday, January 25, 2021 / Article rating: 5.0 The product is bioequivalent and therapeutically equivalent to Actigall capsules, 300 mg, of Allergan Sales, LLC. The US market for the capsule is approximately USD 45 million, according to IQVIA MAT November 2020 data.
Lupin gets USFDA nod for Sevelamer Carbonate tablets; stock gains 2 per cent Lupin gets USFDA nod for Sevelamer Carbonate tablets; stock gains 2 per cent Apurva Joshi / Monday, January 25, 2021 / Article rating: 5.0 Lupin Limited gets approval from United States Food & Drug Administration (USFDA) for its Sevelamer Carbonate tablets, 800 mg. It is a generic equivalent of Renvela tablets, 800 mg of Genzyme Corporation.
Five stocks with buying interest Five stocks with buying interest DSIJ Intelligence / Monday, January 25, 2021 / Article rating: 3.9 The market opened in green on January 25, 2021, overall volumes in futures & options currently stand at 3,42,07,296 contracts with a turnover of Rs. 31,26,119.13 crore.
Five stocks with selling interest Five stocks with selling interest DSIJ Intelligence / Monday, January 25, 2021 / Article rating: 4.1 The market opened in green on January 25, 2021, overall volumes in futures & options currently stand at 3,42,07,296 contracts with a turnover of Rs. 31,26,119.13 crore.
Ten stocks close to their 52-week high Ten stocks close to their 52-week high DSIJ Intelligence / Monday, January 25, 2021 / Article rating: 3.7 The market opened in green on January 25, 2021.
Caplin Point falls despite getting USFDA approval for Argatroban injection Caplin Point falls despite getting USFDA approval for Argatroban injection DSIJ Intelligence / Monday, January 25, 2021 / Article rating: 3.0 The subsidiary company of Caplin Point Laboratories Ltd namely, Caplin Steriles Limited informed that it has received final approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Argatroban injection, 50 mg/50 ml (1 mg/ml) single-dose vial presentation.
Nifty: Formation of a top or a mere pullback? Nifty: Formation of a top or a mere pullback? DSIJ Intelligence-3 / Monday, January 25, 2021 / Article rating: 4.6 It’s said that markets give us hints well in advance of what is going to happen in the coming days. So, here are a few interesting observations witnessed in the markets last week, which is signalling that something big is going to happen as these observations are aligned with a host of events, which are lined up in the coming weeks.
RIL results beat street estimates; retail segment reports highest ever quarterly EBITDA RIL results beat street estimates; retail segment reports highest ever quarterly EBITDA DSIJ Intelligence / Friday, January 22, 2021 / Article rating: 3.5 Reliance Industries on Friday dropped out their results of Q3FY21.
Alembic gets USFDA nod for Midodrine Hydrochloride Tablets Alembic gets USFDA nod for Midodrine Hydrochloride Tablets DSIJ Intelligence / Friday, January 22, 2021 / Article rating: 4.7 Drug manufacturer, Alembic Pharmaceuticals informed the exchanges on Friday that it had secured approval from the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Midodrine Hydrochloride Tablets USP, 2.5 mg, 5 mg, and 10 mg.